Skip to content

An observational study of herbal medicine treatment in obstructive airways diseases(asthma or chronic obstructive pulmonary disease) patients

An observational study of herbal medicine treatment in obstructive airways diseases(asthma or chronic obstructive pulmonary disease) patients

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
CRIS
Registry ID
KCT0004919
Enrollment
50
Registered
2020-04-14
Start date
2019-02-26
Completion date
Unknown
Last updated
2020-04-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

Dunsan Korean Medicine Hospital of Daejeon University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. aged = 19 years 2. A person diagnosed with chronic obstructive pulmonary disease (COPD) in the GOLD standard or asthma in the GINA standard(including those who submitted documents diagnosed with asthma or chronic obstructive pulmonary disease at other hospitals) 3. patients who voluntarily agreed to a clinical research agreement

Exclusion criteria

Exclusion criteria: 1. presence of severe respiratory disease other than asthma or COPD(ex. cystic fibrosis, pneumonia, interstitial lung disease, lung cancer, etc.) 2. history of abuse or dependence on alcohol or other substances 3. history or presence of clinically relevant cardiovascular, renal, metabolic, haematological, neurological, psychiatric, systemic, infectious disease, or malignant tumour(except where there is no recurrence for more than 5 years after surgery) 4. have a disease that can affect drug absorption or have digestive disorders after surgery related to it 5. history of hypersensitivity and allergies to research-related drugs 6. pregnant or breast-feeding 7. judged by the investigators to be inappropriate for the clinical study

Design outcomes

Primary

MeasureTime frame
Pulmonary function Test(FEV1, FVC, FEV1/FVC)

Secondary

MeasureTime frame
mCAMSOM-V(modified Clinical Asthma Measurement Scale in Oriental Medicine-V);PEFR(Peak expiratory flow rate);6-minute walk test;modified Borg Scale;mMRC(modified medical research council);SGRQ(St. George's Respiratory Questionnaire);CAT(COPD assessment test)(for COPD patients only);ACT(Asthma control test)(for asthma patients only);Biomarker (CRP, Fibrinogen, neutrophil, TNF-a, IL-4, IL-5, IL-6, IL-13, IgE, eosinophil);BMI(body mass index);IMPSS(Integrative Medicine Patient Satisfaction Scale);Number of using rescue drugs

Countries

Korea, Republic of

Contacts

Public ContactYeeRan Lyu

Dunsan Korean Medicine Hospital of Daejeon University

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026